Castro H C, Fernandes M, Zingali R B
Departamento de Bioquímica Médica, ICB/CCS, Universidade Federal do Rio de Janeiro, Brazil.
Toxicon. 1999 Oct;37(10):1403-16. doi: 10.1016/s0041-0101(99)00087-2.
Bothrojaracin, a 27 kDa protein isolated from Bothrops jararaca venom, forms a non-covalent complex with thrombin, thus blocking its activity. We have previously identified a bothrojaracin-like protein in B. alternatus venom [Castro, H.C., Dutra, D.L.S., Oliveira-Carvalho, A.L., Zingali, R.B., 1998. Bothroalternin, an inhibitor of thrombin from the venom of Bothrops alternatus. Toxicon 36, 1903-1912]. In this report, we have examined snake venoms from six different Bothrops species (B. atrox, B. cotiara, B. jararacussu, B. moojeni and B. neuwiedi), from Lachesis muta and from Crotalus durissus terrificus for the presence of bothrojaracin-like proteins, which we define here as 27 kDa proteins that are immunologically related to bothrojaracin and that inhibit thrombin-induced platelet aggregation. The immunological analysis of these venoms by different techniques indicated the existence of at least one protein recognized by anti-bothrojaracin serum in all venoms tested. Bothrojaracin-like proteins were purified from all crude venoms, except for C. d. terrificus, by a single-step procedure using a thrombin affinity column (PPACK-thrombin-Sepharose). Retained material that inhibits thrombin-induced platelet aggregation was found in a different proportion in each species. Under non-reducing conditions, SDS-PAGE of this material revealed several bands between 20-60 kDa; only those bands corresponding to 27 kDa were recognized by anti-bothrojaracin serum. ELISA confirmed the greater bothrojaracin immunoreactivity of proteins present in B. atrox and B. cotiara as compared to other Bothrops species. Smaller amounts of proteins related to bothrojaracin were found in L. muta venom and were absent from the venom of C. d. terrificus. Our results thus suggest that bothrojaracin-like proteins are widely distributed among Bothrops genera.
从巴西矛头蝮蛇毒中分离出的27 kDa蛋白质——矛头蝮蛇凝血酶抑制剂,与凝血酶形成非共价复合物,从而阻断其活性。我们之前在变纹矛头蝮蛇毒中鉴定出一种类似矛头蝮蛇凝血酶抑制剂的蛋白质[卡斯特罗,H.C.,杜特拉,D.L.S.,奥利维拉 - 卡瓦略,A.L.,津加利,R.B.,1998年。变纹矛头蝮蛇毒凝血酶抑制剂。《毒素学》36卷,1903 - 1912页]。在本报告中,我们检测了六种不同矛头蝮属蛇类(矛头蝮、科蒂拉矛头蝮、巴西矛头蝮、穆杰尼矛头蝮和纽氏矛头蝮)、巨蝮属的巨蝮以及三色矛头蝮的蛇毒中是否存在类似矛头蝮蛇凝血酶抑制剂的蛋白质,我们在此将其定义为与矛头蝮蛇凝血酶抑制剂具有免疫相关性且能抑制凝血酶诱导的血小板聚集的27 kDa蛋白质。通过不同技术对这些蛇毒进行免疫分析表明,在所有测试的蛇毒中至少存在一种能被抗矛头蝮蛇凝血酶抑制剂血清识别的蛋白质。除三色矛头蝮外,使用凝血酶亲和柱(PPACK - 凝血酶 - 琼脂糖)通过单步程序从所有粗蛇毒中纯化出了类似矛头蝮蛇凝血酶抑制剂的蛋白质。在每个物种中发现抑制凝血酶诱导的血小板聚集的保留物质的比例不同。在非还原条件下,该物质的SDS - PAGE显示在20 - 60 kDa之间有几条带;只有对应27 kDa的那些带能被抗矛头蝮蛇凝血酶抑制剂血清识别。酶联免疫吸附测定(ELISA)证实,与其他矛头蝮属物种相比,矛头蝮和科蒂拉矛头蝮蛇毒中存在的蛋白质具有更高的矛头蝮蛇凝血酶抑制剂免疫反应性。在巨蝮蛇毒中发现了少量与矛头蝮蛇凝血酶抑制剂相关的蛋白质,而在三色矛头蝮蛇毒中则不存在。因此,我们的结果表明类似矛头蝮蛇凝血酶抑制剂的蛋白质在矛头蝮属中广泛分布。